Q1 2016 Holdings
Filed 2016-05-16 | 22 holdings | $18.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $12.2M | 416,879 | 66.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $5.8M | 70,000 | 31.5% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $265.0K | 63,146 | 1.4% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $16.2K | 757,935 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $12.7K | 705,159 | 0.1% |
| Celator Pharmaceuticals Inc | COM | 15089R102 | $9.2K | 835,408 | 0.1% |
| Seattle Genetics Inc | COM | 812578102 | $8.2K | 233,600 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $7.2K | 100,000 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $7.2K | 820,015 | 0.0% |
| Aradigm Corp(ARDMEUR) | COM NO PAR NEW | 038505400 | $4.9K | 1,101,513 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.1K | 234,220 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $2.6K | 645,685 | 0.0% |
| Avexis Inc | COM | 05366U100 | $2.3K | 83,276 | 0.0% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $2.1K | 315,025 | 0.0% |
| Akari Therapeutics PLC | SPONSORED ADR | 00972G108 | $2.0K | 139,899 | 0.0% |
| Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | $1.6K | 176,710 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $1.6K | 93,331 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $1.6K | 168,000 | 0.0% |
| Sophiris BIO Inc | COM NEW | 83578Q209 | $786 | 546,088 | 0.0% |
| Nexvet Biopharma PUB LTD Co | ORD SHS | G6503X109 | $511 | 154,840 | 0.0% |
| Essa Pharma Inc | COM | 29668H104 | $91 | 28,100 | 0.0% |
| Oncogenex Pharmaceuticals Inc | COM | 68230A106 | $60 | 87,827 | 0.0% |